✦ LIBER ✦

Beyond Imatinib: Second Generation c-KIT Inhibitors for the Management of Gastrointestinal Stromal Tumors

✍ Scribed by Margaret von Mehren

Book ID: 119935076
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 130 KB
Volume: 6
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2006.s.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant and neoadjuvant imatinib therap

Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors

✍ Burton L. Eisenberg; Jonathan C. Trent 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB

## Abstract Although surgery remains the mainstay for the treatment of primary gastrointestinal stromal tumors (GIST), a significant number of patients experience disease recurrence within 5 years of surgery. The emergence of imatinib therapy for the treatment of patients with advanced GIST has off

Management of Gastrointestinal Stromal T

Management of Gastrointestinal Stromal Tumors: Looking Beyond the Knife. An Update on the Role of Adjuvant and Neoadjuvant Imatinib Therapy

✍ Richa Pandey, Rajan Kochar 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 513 KB

Gain-of-Function Mutations of c-kit in H

Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors

✍ Hirota, S. 📂 Article 📅 1998 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 654 KB

Effect of loss of heterozygosity of the

Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors

✍ Hirotoshi Kikuchi; Masayoshi Yamamoto; Yoshihiro Hiramatsu; Megumi Baba; Manabu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

212 POSTER A phase II study of the KIT i

212 POSTER A phase II study of the KIT inhibitor XL820 in patients with advanced gastrointestinal stromal tumors (GIST) resistant to or intolerant of imatinib and/or sunitinib

✍ A.J. Wagner; S. Yazji; J.A. Morgan; E. Choy; S. George; M. Hohos; M. O'Mara; G.D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The Novel Marker, DOG1, Is Expressed Ubi

The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status

✍ Robert B. West; Christopher L. Corless; Xin Chen; Brian P. Rubin; Subbaya Subram 📂 Article 📅 2004 🏛 American Society for Investigative Pathology 🌐 English ⚖ 966 KB